Navigation Links
Media advisory -- Partnering to Fight TB: The Role of a TB Vaccine PDP
Date:2/14/2011

Partnering to Fight TB: The Role of a TB Vaccine PDP
An Exhibitor's Workshop at the 2011 AAAS Annual Meeting

DATE: SUNDAY, FEBRUARY 20, 1:00-2:00 PM

VENUE: 2011 AAAS ANNUAL MEETING, WASHINGTON CONVENTION CENTER, ROOM 158AB

Speakers at the workshop will provide an overview of the state of the global TB epidemic and efforts to develop TB vaccines; the role of non-profit product development partnerships such as Aeras; and ways that scientists and researchers can add their voices to a global call for action on TB.

SPEAKERS:

  • Lewellys F. Barker, MD, Senior Medical Advisor, Aeras
  • David Bryden, Senior Program Policy Officer at the Infectious Diseases Society of America's Center for Global Health Policy
  • Claire Wingfield, TB/HIV Project Coordinator at the Treatment Action Group

BACKGROUND:

TB is one of the world's deadliest infectious diseases, killing nearly 2 million men, women and children every year. Despite global efforts to prevent and treat TB, the epidemic is becoming more complex and difficult to diagnose and treat due in large part to the emergence of drug-resistant forms of TB and the emergence of the HIV epidemic. TB is responsible for the majority of AIDS deaths in Africa. The currently available vaccine, BCG, provides some protection against pediatric TB but is unreliable in protecting adult pulmonary TB, the most common form of the disease. New TB vaccines are urgently needed as part of a comprehensive effort to stop TB.


'/>"/>

Contact: Annmarie Leadman
aleadman@aeras.org
240-599-3018
Aeras Global TB Vaccine Foundation
Source:Eurekalert

Page: 1

Related biology news :

1. October 2008 GEOLOGY and GSA TODAY media highlights
2. Mediator in communication between neurons and muscle cells found
3. December 2008 Geology and GSA Today media highlights
4. December Geosphere media highlights
5. January GEOLOGY media highlights
6. January-February GSA Bulletin media highlights
7. BIO-key(R) Fingerprint Biometrics Media Spotlights
8. February 2009 Geology and GSA Today media highlights
9. Scripps scientists create first crystal structure of an intermediate particle in virus assembly
10. Mass media often failing in its coverage of global warming, says climate researcher
11. Patience pays off with methanol for uranium bioremediation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: